Verona, M.; Rubagotti, S.; Croci, S.; Sarpaki, S.; Borgna, F.; Tosato, M.; Vettorato, E.; Marzaro, G.; Mastrotto, F.; Asti, M.
Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting. Molecules 2021, 26, 918.
https://doi.org/10.3390/molecules26040918
AMA Style
Verona M, Rubagotti S, Croci S, Sarpaki S, Borgna F, Tosato M, Vettorato E, Marzaro G, Mastrotto F, Asti M.
Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting. Molecules. 2021; 26(4):918.
https://doi.org/10.3390/molecules26040918
Chicago/Turabian Style
Verona, Marco, Sara Rubagotti, Stefania Croci, Sophia Sarpaki, Francesca Borgna, Marianna Tosato, Elisa Vettorato, Giovanni Marzaro, Francesca Mastrotto, and Mattia Asti.
2021. "Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting" Molecules 26, no. 4: 918.
https://doi.org/10.3390/molecules26040918
APA Style
Verona, M., Rubagotti, S., Croci, S., Sarpaki, S., Borgna, F., Tosato, M., Vettorato, E., Marzaro, G., Mastrotto, F., & Asti, M.
(2021). Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting. Molecules, 26(4), 918.
https://doi.org/10.3390/molecules26040918